Search results
Results from the WOW.Com Content Network
As of 2023, Annual Review of Pharmacology and Toxicology is being published as open access, under the Subscribe to Open model. [1] As of 2024, Journal Citation Reports lists the journal's 2023 impact factor as 11.2, ranking it second of 106 journal titles in the category "Toxicology" and ninth of 354 titles in the category "Pharmacology ...
Mount Sinai Journal of Medicine: Medicine: John Wiley & Sons: English: 1934–2012 Movement Disorders: Neurology: Wiley-Liss: English: 1986–present Myanmar Medical Journal: Medicine: Myanmar Medical Association: English: 1953–present Nano Biomedicine and Engineering: Medicine: Open-Access House of Science and Technology: English: 2009–present
The journal is abstracted and indexed in: EBSCO databases; Biological Abstracts; Chemical Abstracts Service; Current Contents/Life Sciences; Embase; ProQuest databases; Index Medicus, MEDLINE/PubMed; Science Citation Index Expanded; According to the Journal Citation Reports, the journal has a 2023 impact factor of 2.9. [5]
This is a list of notable medical and scientific journals that publish articles in pharmacology and the pharmaceutical sciences This is a dynamic list and may never be able to satisfy particular standards for completeness.
While these journals still did not receive an impact factor until the next year, they did contribute citations to the calculation of other journals' impact factors. [ 4 ] [ 5 ] In July 2022, Clarivate announced that journals in the ESCI obtain an impact factor effective from JCR Year 2022 first released in June 2023.
It was established in 1969 as Pharmacological Research Communications, obtaining its current name in 1989. [1] [2] It is published by Elsevier and the editor-in-chief is Emilio Clementi (University of Milan). According to the Journal Citation Reports, the journal has a 2023 impact factor of 9.1.
Pharmacological Reviews is a quarterly peer-reviewed scientific journal publishing review articles on all aspects of pharmacology and related topics. It is published by the American Society for Pharmacology and Experimental Therapeutics. The editor-in-chief is Lynette C. Daws (The University of Texas Health Science Center at San Antonio).
As of 2023, Annual Review of Medicine is being published as open access, under the Subscribe to Open model. [1] As of 2024, Journal Citation Reports gives the journal a 2023 impact factor of 15.1, ranking it third of 189 titles in the category "Medicine, Research & Experimental". [2]